$5650 | Single User
$6650 | Multi User
$8150 | Corporate License
$10000 | Enterprise License

Human Microbiome Market by Indication (Obesity, Cancer), Application (Therapeutic, Diagnostic), Product (Prebiotics, Food, Drugs), Product Research (Instruments, Consumables), Technology Research (HTS, Omics Technologies) - Global Forecast to 2025
[Report Updated: 06-03-2017]

Published by MarketsandMarkets: 06 Mar 2017 | 47337 | In Stock

Introduction

The global human microbiome market is estimated to reach USD 899.1 million by 2025, growing at a CAGR of 21.1% during the forecast period (2022–2025).

Factors such as increased focus on human microbiome therapy, growing demand for human microbiomes as new validated targets for drug development, and the need for early disease detection and diagnosis are expected to drive the growth of the human microbiome market.

By product, the global human microbiome market is classified into probiotics, prebiotics, foods, medical foods, supplements, diagnostic devices, and drugs. The expectation that microbiome products, which will aid in the early-stage treatment of chronic diseases and various disorders, will be available in the market in the future is a key driver for the growth of this market. Other factors such as the rise in aging population, incidence of chronic health problems, and the need to cut healthcare costs will increase the adoption of microbiome-derived products. However, patent applications of microbiome-derived products will require clinical evidence and regulatory approvals; therefore, the promise of significant investment in this segment is uncertain.

Europe currently forms the largest human microbiome market in terms of demand for prebiotics and probiotics. The North American region is expected to register the highest growth rate due to its immense growth opportunities. Scientific evidence of health benefits of certain ingredients such as probiotics, prebiotics, etc. and the search for new opportunities to add value to the existing products are also expected to propel the global market growth. The demand for prebiotics and probiotics is increasing across various regions owing to the awareness among consumers regarding the favorable benefits of the microbiome community also referred as “friendly” bacteria. Most of the consumers prefer these products for maintaining good health and to use enhanced efficiency of ingredients, which offer products with bio-therapeutic properties. With the advancement in technology, the usage of probiotics is likely to extend beyond the current arena of gut, dental, and immune health to several other areas of human health.

Moreover, the rising incidence of cardiac diseases and other diseases such as diabetes and obesity are also expected to contribute to the growth of the human microbiome market. Increasing side effects and diminishing of human gut flora, due to excessive use of antibiotics, is likely to drive the growth of the human microbiome market. The application market is also expected to be a prominent segment owing to the use of microbiome as diagnostics and therapeutics.

The competitive landscape covers the current product pipelines of the industry players in various stages of the clinical trial development. The company profiles comprise the basic views on the key players in the human microbiome market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future.

The above mentioned market research data, market potential, future market size, and forecast of future trends will help the key players and new entrants to make the necessary decisions regarding market penetration, product development/innovation, market development, market diversification, and competitive assessment, product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful in the market.

Research Coverage:

The report provides a picture on human microbiome across different industry verticals and regions. It aims at estimating the market size and future growth potential of this market across different segments such as product, disease, application, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market by providing them the closest approximations of the revenue numbers for the overall human microbiome market and the subsegments. This report will help stakeholders to better understand the competitor landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. The report also helps the stakeholders to understand the pulse of the market and provides them information on key market drivers, restraints, challenges, and opportunities.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

The report provides insights on the following pointers:

 Market Penetration: Comprehensive information on the product portfolios offered by the top players in the human microbiome market. The report analyzes the human microbiome market by product, application, disease, and region

 Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the human microbiome market

 Market Development: Comprehensive information about the lucrative emerging markets, by product and region

 Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the human microbiome market

 Competitive Assessment: In-depth assessment of market shares, growth strategies, products, and manufacturing capabilities of leading players in the human microbiome market

Table of Contents
for Human Microbiome Market by Indication (Obesity, Cancer), Application (Therapeutic, Diagnostic), Product (Prebiotics, Food, Drugs), Product Research (Instruments, Consumables), Technology Research (HTS, Omics Technologies) - Global Forecast to 2025 [Report Updated: 06-03-2017]

  • TABLE OF CONTENTS

    1 INTRODUCTION 15

    1.1 OBJECTIVES OF THE STUDY 15

    1.2 MARKET DEFINITION 15

    1.3 MARKET SCOPE 15

    1.3.1 MARKETS COVERED 16

    1.3.2 YEARS CONSIDERED FOR THE STUDY 17

    1.4 CURRENCY 18

    1.5 LIMITATIONS 18

    1.6 STAKEHOLDERS 18

    2 RESEARCH METHODOLOGY 19

    2.1 RESEARCH APPROACH 19

    2.2 MARKET SIZE ESTIMATION 20

    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 23

    2.3.1 KEY DATA FROM SECONDARY SOURCES 24

    2.3.2 KEY DATA FROM PRIMARY SOURCES 24

    2.3.3 KEY INDUSTRY INSIGHTS 25

    2.3.4 ASSUMPTIONS 25

    3 EXECUTIVE SUMMARY 26

    4 PREMIUM INSIGHTS 30

    4.1 HUMAN MICROBIOME : MARKET OVERVIEW 30

    4.2 GLOBAL HUMAN MICROBIOME MARKET, BY PRODUCT (2022) 31

    4.3 HUMAN MICROBIOME MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 32

    4.4 HUMAN MICROBIOME MARKET: GEOGRAPHIC MIX 33

    4.5 HUMAN MICROBIOME MARKET: DEVELOPING VS. DEVELOPED REGIONS 33

    4.6 HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY 34

    5 MARKET OVERVIEW 35

    5.1 INTRODUCTION 36

    5.2 MARKET DYNAMICS 36

    5.2.1 DRIVERS 37

    5.2.1.1 Increased focus on human microbiome therapy 37

    5.2.1.2 Human microbiome as new validated target for drug development 37

    5.2.1.3 Human microbiome for early disease detection and diagnosis 37

    5.2.2 RESTRAINTS 38

    5.2.2.1 Lack of expertise and detailed research 38

    5.2.2.2 Barriers in proving the causal link between dysbiosis and disease 38

    5.2.3 OPPORTUNITIES 38

    5.2.3.1 Investigational New Drug (IND) requirements for fecal microbiota 38

    5.2.3.2 Increasing collaborations create growth opportunities 38

    5.2.4 CHALLENGE 39

    5.2.4.1 Government regulations 39

    5.2.5 BURNING ISSUES 39

    5.2.5.1 Abundant opportunities in the human microbiome field and tremendous research investments 39

    5.2.5.2 Development of human microbiome therapeutic products 40

    5.3 HUMAN MICROBIOME MARKET: PATENTS 41

    5.4 HUMAN MICROBIOME MARKET: FUNDING 42

    6 HUMAN MICROBIOME MARKET, BY PRODUCT 43

    6.1 INTRODUCTION 44

    6.2 PROBIOTICS 45

    6.3 FOODS 46

    6.4 PREBIOTICS 47

    6.5 MEDICAL FOODS 48

    6.6 DIAGNOSTIC DEVICES 49

    6.7 DRUGS 50

    6.8 OTHER PROBIOTIC SUPPLEMENTS 51

    7 HUMAN MICROBIOME MARKET, BY APPLICATION 52

    7.1 INTRODUCTION 53

    7.2 THERAPEUTICS 54

    7.3 DIAGNOSTICS 55

    8 HUMAN MICROBIOME MARKET, BY DISEASE 56

    8.1 INTRODUCTION 57

    8.2 ACUTE DIARRHEA 58

    8.3 OBESITY 59

    8.4 DIABETES 60

    8.5 AUTOIMMUNE DISORDERS 61

    8.6 CANCER 62

    8.7 MENTAL DISORDERS 63

    8.8 OTHER DISEASES 64

    9 HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY PRODUCT 65

    9.1 INTRODUCTION 66

    9.2 INSTRUMENTS 66

    9.2.1 LABORATORY INSTRUMENTS 67

    9.2.2 ANALYZERS 69

    9.3 CONSUMABLES 70

    9.3.1 KITS 71

    9.3.2 REAGENTS 72

    10 HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY 74

    10.1 INTRODUCTION 75

    10.2 CELL CULTURE TECHNOLOGY 75

    10.3 HIGH-THROUGHPUT TECHNOLOGY 76

    10.4 OMICS TECHNOLOGY 77

    10.5 COMPUTATIONAL TOOLS 78

    11 HUMAN MICROBIOME MARKET, BY REGION 80

    11.1 INTRODUCTION 81

    11.2 NORTH AMERICA 83

    11.2.1 U.S. 88

    11.2.2 CANADA 91

    11.3 EUROPE 95

    11.4 ASIA-PACIFIC 100

    11.5 REST OF THE WORLD (ROW) 104

    12 COMPETITIVE LANDSCAPE 107

    12.1 OVERVIEW 107

    12.2 COMPETITIVE SITUATION AND TRENDS 108

    12.2.1 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 108

    12.2.2 EXPANSIONS 109

    12.2.3 PRODUCT LAUNCHES AND APPROVALS 110

    12.2.4 OTHER DEVELOPMENTS 111

    13 COMPANY PROFILES 112

    (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

    13.1 ENTEROME BIOSCIENCE 113

    13.2 E.I. DU PONT DE NEMOURS AND COMPANY 115

    13.3 MERCK & CO., INC. 119

    13.4 METABIOMICS CORPORATION 121

    13.5 YAKULT HONSHA CO., LTD. 123

    13.6 MICROBIOME THERAPEUTICS, LLC 126

    13.7 OSEL, INC. 128

    13.8 SECOND GENOME, INC. 129

    13.9 VITHERA PHARMACEUTICALS 131

    13.10 VEDANTA BIOSCIENCES, INC. 132

    *Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

    14 APPENDIX 134

    14.1 INSIGHTS FROM INDUSTRY EXPERTS 134

    14.2 DISCUSSION GUIDE 135

    14.3 OTHER DEVELOPMENTS 138

    14.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 143

    14.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 145

    14.6 AVAILABLE CUSTOMIZATIONS 146

    14.7 RELATED REPORTS 147

    14.8 AUTHOR DETAILS 148

List Of Tables
in Human Microbiome Market by Indication (Obesity, Cancer), Application (Therapeutic, Diagnostic), Product (Prebiotics, Food, Drugs), Product Research (Instruments, Consumables), Technology Research (HTS, Omics Technologies) - Global Forecast to 2025 [Report Updated: 06-03-2017]

LIST OF TABLES


TABLE 1 HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2022–2025 (USD MILLION) 45

TABLE 2 HUMAN MICROBIOME MARKET SIZE FOR PROBIOTICS, BY REGION,

2022-2025 (USD MILLION) 46

TABLE 3 HUMAN MICROBIOME MARKET FOR FOODS, BY REGION,

2022-2025 (USD MILLION) 47

TABLE 4 HUMAN MICROBIOME MARKET SIZE FOR PREBIOTICS, BY REGION,

2022-2025 (USD MILLION) 48

TABLE 5 HUMAN MICROBIOME MARKET SIZE FOR MEDICAL FOODS, BY REGION,

2022-2025 (USD MILLION) 48

TABLE 6 HUMAN MICROBIOME MARKET SIZE FOR DIAGNOSTIC DEVICES,

BY REGION, 2020–2025 (USD MILLION) 49

TABLE 7 HUMAN MICROBIOME MARKET SIZE FOR DRUGS, BY REGION,

2022–2025 (USD MILLION) 50

TABLE 8 HUMAN MICROBIOME MARKET SIZE FOR OTHER PROBIOTIC SUPPLEMENTS,

BY REGION, 2022-2025 (USD MILLION) 51

TABLE 9 HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2022–2025 (USD MILLION) 53

TABLE 10 HUMAN MICROBIOME MARKET SIZE FOR THERAPEUTIC APPLICATIONS,

BY REGION, 2022–2025 (USD MILLION) 54

TABLE 11 HUMAN MICROBIOME MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2021–2025 (USD MILLION) 55

TABLE 12 HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2022–2025 (USD MILLION) 58

TABLE 13 HUMAN MICROBIOME MARKET SIZE FOR ACUTE DIARRHEA, BY REGION,

2022–2025 (USD MILLION) 59

TABLE 14 HUMAN MICROBIOME MARKET SIZE FOR OBESITY, BY REGION,

2021–2025 (USD MILLION) 60

TABLE 15 HUMAN MICROBIOME MARKET SIZE FOR DIABETES, BY REGION,

2022–2025 (USD MILLION) 61

TABLE 16 HUMAN MICROBIOME MARKET SIZE FOR AUTOIMMUNE DISORDERS,

BY REGION, 2021–2025 (USD MILLION) 61

TABLE 17 HUMAN MICROBIOME MARKET SIZE FOR CANCER, BY REGION,

2022–2025 (USD MILLION) 62

TABLE 18 HUMAN MICROBIOME MARKET SIZE FOR MENTAL DISORDERS,

BY REGION, 2022–2025 (USD MILLION) 63

TABLE 19 HUMAN MICROBIOME MARKET SIZE FOR OTHER DISEASES,

BY REGION, 2021–2025 (USD MILLION) 64

TABLE 20 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,

BY PRODUCT, 2014–2021 (USD MILLION) 66

TABLE 21 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS,

BY TYPE, 2014–2021 (USD MILLION) 66

TABLE 22 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS,

BY REGION, 2014–2021 (USD MILLION) 67

TABLE 23 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY COUNTRY, 2014–2021 (USD MILLION) 67

TABLE 24 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR LABORATORY INSTRUMENTS, BY REGION, 2014–2021 (USD MILLION) 68

TABLE 25 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2014–2021 (USD MILLION) 68

TABLE 26 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR ANALYZERS,

BY REGION, 2014–2021 (USD MILLION) 69

TABLE 27 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR ANALYZERS, BY COUNTRY, 2014–2021 (USD MILLION) 69

TABLE 28 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014–2021 (USD MILLION) 70

TABLE 29 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY REGION, 2014–2021 (USD MILLION) 70

TABLE 30 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY COUNTRY, 2014–2021 (USD MILLION) 71

TABLE 31 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR KITS, BY REGION, 2014–2021 (USD MILLION) 71

TABLE 32 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR KITS, BY COUNTRY, 2014–2021 (USD MILLION) 72

TABLE 33 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR REAGENTS,

BY REGION, 2014–2021 (USD MILLION) 72

TABLE 34 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR REAGENTS, BY COUNTRY, 2014–2021 (USD MILLION) 73

TABLE 35 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 75

TABLE 36 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CELL CULTURE TECHNOLOGY, BY REGION, 2014–2021 (USD MILLION) 75

TABLE 37 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CELL CULTURE TECHNOLOGY, BY COUNTRY, 2014–2021 (USD MILLION) 76

TABLE 38 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR HIGH-THROUGHPUT TECHNOLOGY, BY REGION, 2014–2021 (USD MILLION) 76

TABLE 39 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR HIGH-THROUGHPUT TECHNOLOGY, BY COUNTRY, 2014–2021 (USD MILLION) 77

TABLE 40 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR OMICS TECHNOLOGY, BY REGION, 2014–2021 (USD MILLION) 77

TABLE 41 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR OMICS TECHNOLOGY, BY COUNTRY, 2014–2021 (USD MILLION) 78

TABLE 42 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR COMPUTATIONAL TOOLS, BY REGION, 2014–2021 (USD MILLION) 78

TABLE 43 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR COMPUTATIONAL TOOLS, BY COUNTRY, 2014–2021 (USD MILLION) 79

TABLE 44 HUMAN MICROBIOME MARKET SIZE, BY REGION, 2022–2025 (USD MILLION) 82

TABLE 45 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 82

TABLE 46 NORTH AMERICA: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT,

2022–2025 (USD MILLION) 85

TABLE 47 NORTH AMERICA: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION,

2022–2025 (USD MILLION) 85

TABLE 48 NORTH AMERICA: HUMAN MICROBIOME MARKET SIZE, BY DISEASE,

2022–2025 (USD MILLION) 86

TABLE 49 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,

BY PRODUCT, 2014–2021 (USD MILLION) 86

TABLE 50 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014–2021 (USD MILLION) 87

TABLE 51 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014–2021 (USD MILLION) 87

TABLE 52 NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,

BY TECHNOLOGY, 2014–2021 (USD MILLION) 87

TABLE 53 U.S.: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT,

2022–2025 (USD MILLION) 88

TABLE 54 U.S.: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION,

2022–2025 (USD MILLION) 89

TABLE 55 U.S.: HUMAN MICROBIOME MARKET SIZE, BY DISEASE,

2022–2025 (USD MILLION) 89

TABLE 56 U.S.: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 90

TABLE 57 U.S.: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014–2021 (USD MILLION) 90

TABLE 58 U.S.: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014–2021 (USD MILLION) 90

TABLE 59 U.S.: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 91

TABLE 60 CANADA: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT,

2022–2025 (USD MILLION) 91

TABLE 61 CANADA : HUMAN MICROBIOME MARKET SIZE, BY APPLICATION,

2022–2025 (USD MILLION) 92

TABLE 62 CANADA : HUMAN MICROBIOME MARKET SIZE, BY DISEASE,

2022–2025 (USD MILLION) 92

TABLE 63 CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,

BY PRODUCT, 2014–2021 (USD MILLION) 93

TABLE 64 CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014–2021 (USD MILLION) 93

TABLE 65 CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014–2021 (USD MILLION) 94

TABLE 66 CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,

BY TECHNOLOGY, 2014–2021 (USD MILLION) 94

TABLE 67 EUROPE: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT,

2022–2025 (USD MILLION) 95

TABLE 68 EUROPE: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION,

2022–2025 (USD MILLION) 97

TABLE 69 EUROPE: HUMAN MICROBIOME MARKET SIZE, BY DISEASE,

2022–2025 (USD MILLION) 97

TABLE 70 EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,

BY PRODUCT, 2014–2021 (USD MILLION) 98

TABLE 71 EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014–2021 (USD MILLION) 98

TABLE 72 EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014–2021 (USD MILLION) 99

TABLE 73 EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,

BY TECHNOLOGY, 2014–2021 (USD MILLION) 99

TABLE 74 ASIA-PACIFIC: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT,

2022–2025 (USD MILLION) 101

TABLE 75 ASIA-PACIFIC: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION,

2020–2025 (USD MILLION) 101

TABLE 76 ASIA-PACIFIC: HUMAN MICROBIOME MARKET SIZE, BY DISEASE,

2022–2025 (USD MILLION) 102

TABLE 77 APAC: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,

BY PRODUCT, 2014–2021 (USD MILLION 102

TABLE 78 APAC: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014–2021 (USD MILLION) 103

TABLE 79 APAC: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014–2021 (USD MILLION) 103

TABLE 80 APAC: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,

BY TECHNOLOGY, 2014–2021 (USD MILLION) 103

TABLE 81 ROW: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT,

2022–2025 (USD MILLION) 104

TABLE 82 ROW: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION,

2022–2025 (USD MILLION) 104

TABLE 83 ROW: HUMAN MICROBIOME MARKET SIZE, BY DISEASE,

2022–2025 (USD MILLION) 105

TABLE 84 ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,

BY PRODUCT, 2014–2021 (USD MILLION) 105

TABLE 85 ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014–2021 (USD MILLION) 106

TABLE 86 ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014–2021 (USD MILLION) 106

TABLE 87 ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE,

BY TECHNOLOGY, 2014–2021 (USD MILLION) 106

TABLE 88 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013–2016 108

TABLE 89 EXPANSIONS, 2013–2016 109

TABLE 90 PRODUCT LAUNCHES AND APPROVALS, 2013–2016 110

TABLE 91 OTHER DEVELOPMENTS, 2013–2016 111

List Of Figures, Charts and Diagrams
in Human Microbiome Market by Indication (Obesity, Cancer), Application (Therapeutic, Diagnostic), Product (Prebiotics, Food, Drugs), Product Research (Instruments, Consumables), Technology Research (HTS, Omics Technologies) - Global Forecast to 2025 [Report Updated: 06-03-2017]

LIST OF FIGURES


FIGURE 1 HUMAN MICROBIOME: MARKET SEGMENTATION 16

FIGURE 2 HUMAN MICROBIOME RESEARCH SPENDING: MARKET SEGMENTATION 16

FIGURE 3 RESEARCH DESIGN 19

FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 21

FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 21

FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 22

FIGURE 7 PROBIOTICS SEGMENT TO DOMINATE THE HUMAN MICROBIOME MARKET DURING THE FORECAST PERIOD 26

FIGURE 8 CONSUMABLES SEGMENT TO WITNESS THE HIGHEST GROWTH RATE IN THE MICROBIOME RESEARCH SPENDING MARKET FROM 2016 TO 2021 27

FIGURE 9 CELL CULTURE TECHNOLOGIES TO DOMINATE THE HUMAN MICROBIOME RESEARCH SPENDING MARKET IN 2015 28

FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL HUMAN MICROBIOME MARKET, 2022 29

FIGURE 11 GROWING PREVALENCE OF LIFESTYLE DISEASES AND INCREASING ACCEPTANCE OF MICROBIOME-BASED PRODUCTS ARE MAJOR GROWTH DRIVERS 30

FIGURE 12 PROBIOTICS SEGMENT DOMINATED THE HUMAN MICROBIOME MARKET IN 2022 31

FIGURE 13 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE HUMAN MICROBIOME MARKET IN 2022-2025 32

FIGURE 14 NORTH AMERICA TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 33

FIGURE 15 DEVELOPED REGIONS TO GROW AT HIGHER CAGRS FROM 2022 TO 2025 33

FIGURE 16 CELL CULTURE TECHNOLOGY SEGMENT DOMINATED THE HUMAN MICROBIOME RESEARCH SPENDING MARKET IN 2015 34

FIGURE 17 HUMAN MICROBIOME MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 36

FIGURE 18 FUNDS PROVIDED FOR MICROBIOME RESEARCH BY VARIOUS MEDICAL RESEARCH AGENCIES 40

FIGURE 19 PROBIOTICS SEGMENT TO COMMAND THE LARGEST SHARE OF THE HUMAN MICROBIOME PRODUCT MARKET BY 2025 44

FIGURE 20 THE THERAPEUTICS SEGMENT TO COMMAND THE LARGEST SHARE OF THE HUMAN MICROBIOME APPLICATIONS MARKET BY 2025 53

FIGURE 21 ACUTE DIARRHEA EXPECTED TO BE THE LARGEST DISEASE SEGMENT OF THE HUMAN MICROBIOME MARKET IN 2022 57

FIGURE 22 GEOGRAPHIC SNAPSHOT (2022): NORTH AMERICA WILL BE THE FASTEST-GROWING REGION BY 2022 81

FIGURE 23 NORTH AMERICA TO GROW AT THE FASTEST RATE IN THE HUMAN MICROBIOME PRODUCT MARKET FROM 2022 TO 2025 84

FIGURE 24 EUROPE: HUMAN MICROBIOME MARKET SNAPSHOT 96

FIGURE 25 COMPANIES ADOPTED AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS AS THE KEY GROWTH STRATEGY OVER THE LAST THREE YEARS 107

FIGURE 26 BATTLE FOR MARKET SHARE: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS ARE KEY GROWTH STRATEGIES FOR MARKET PLAYERS 108

FIGURE 27 GEOGRAPHIC REVENUE MIX OF TOP 3 MARKET PLAYERS 112

FIGURE 28 E.I. DU PONT DE NEMOURS AND COMPANY: COMPANY SNAPSHOT (2015) 115

FIGURE 29 MERCK & CO., INC.: COMPANY SNAPSHOT (2015) 119

FIGURE 30 YAKULT HONSHA CO., LTD.: COMPANY SNAPSHOT (2016) 123

Additional Details

Publisher

MarketsandMarkets

Publisher Information

Reference

47337 | BT 2711

Number of Pages

150

Report Format

PDF

MarketsandMarkets Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Human Papilloma Virus Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Human Drugs For Veterinary Use - Current Trends and Future Commercial Prospects for Crossover Drugs
Human Drugs For Veterinary Use - Current Trends and Future Commercial Prospects for Crossover DrugsS...
01 May 2016 by CBR Pharma Insights USD $2,995 More Info
National Human Genome Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNational Human Genome Research Institute (NHGRI) a subsidiary of National Institutes of Healt...
27 Apr 2016 by Global Data USD $250 More Info
National Human Genome Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNational Human Genome Research Institute (NHGRI) a subsidiary of National Institutes of Healt...
14 Mar 2016 by Global Data USD $250 More Info
Human Immunodeficiency Virus (HIV) - US Drug Forecast and Market Analysis to 2023
Human Immunodeficiency Virus (HIV) - US Drug Forecast and Market Analysis to 2023SummaryHuman immuno...
09 Sep 2015 by Global Data USD $4,995 More Info
Human Immunodeficiency Virus (HIV) - Japan Drug Forecast and Market Analysis to 2023
Human Immunodeficiency Virus (HIV) - Japan Drug Forecast and Market Analysis to 2023SummaryHuman imm...
09 Sep 2015 by Global Data USD $4,995 More Info
Human Immunodeficiency Virus (HIV) - 5EU Drug Forecast and Market Analysis to 2023
Human Immunodeficiency Virus (HIV) - 5EU Drug Forecast and Market Analysis to 2023SummaryHuman immun...
09 Sep 2015 by Global Data USD $6,995 More Info
Human Immunodeficiency Virus (HIV) - Brazil Drug Forecast and Market Analysis to 2023
Human Immunodeficiency Virus (HIV) - Brazil Drug Forecast and Market Analysis to 2023SummaryHuman im...
09 Sep 2015 by Global Data USD $4,995 More Info
Human Immunodeficiency Virus (HIV) - China Drug Forecast and Market Analysis to 2023
Human Immunodeficiency Virus (HIV) - China Drug Forecast and Market Analysis to 2023SummaryHuman imm...
09 Sep 2015 by Global Data USD $4,995 More Info
Human Immunodeficiency Virus (HIV) - Current and Future Players
Human Immunodeficiency Virus (HIV) - Current and Future PlayersSummaryGlobalData has released its ph...
09 Sep 2015 by Global Data USD $2,995 More Info

This report is published by MarketsandMarkets

Download Free Report Summary PDF

Human Microbiome Market by Indication (Obesity, Cancer), Application (Therapeutic, Diagnostic), Product (Prebiotics, Food, Drugs), Product Research (Instruments, Consumables), Technology Research (HTS, Omics Technologies) - Global Forecast to 2025 [Report Updated: 06-03-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...